Blood Grouping Reagents [3491841]
Estimated value
—
Awarded value
—
Suppliers
38
Lots
40
Published
22 Dec 2022
Total lots
40
Awarded
40
Estimated total
£46.2m
Awarded total
—
1.1 Anti-A
Start
—
End
—
Estimated
£1.2m
CPV
1.2 Anti-B
Start
—
End
—
Estimated
£1.2m
CPV
1.3 Anti-A,B
Start
—
End
—
Estimated
£1.2m
CPV
2.1 IgM Anti-D
Start
—
End
—
Estimated
£1.2m
CPV
2.2 Blend Anti-D
Start
—
End
—
Estimated
£1.2m
CPV
3.1 Anti-C
Start
—
End
—
Estimated
£1.2m
CPV
3.2 Anti-E
Start
—
End
—
Estimated
£1.2m
CPV
3.3 Anti-c
Start
—
End
—
Estimated
£1.2m
CPV
3.4 Anti-e
Start
—
End
—
Estimated
£1.2m
CPV
4.1 Anti-JKa
Start
—
End
—
Estimated
£1.2m
CPV
4.2 Anti-JKb
Start
—
End
—
Estimated
£1.2m
CPV
5.1 Anti-M
Start
—
End
—
Estimated
£1.2m
CPV
5.2 Anti-N
Start
—
End
—
Estimated
£1.2m
CPV
6.1 Anti-S
Start
—
End
—
Estimated
£1.2m
CPV
6.2 Anti-s
Start
—
End
—
Estimated
£1.2m
CPV
7.1 Anti-Lea
Start
—
End
—
Estimated
£1.2m
CPV
7.2 Anti-Leb
Start
—
End
—
Estimated
£1.2m
CPV
8.1 Anti-Fya
Start
—
End
—
Estimated
£1.2m
CPV
8.2 Anti-Fyb must be capable of detecting Fyx
Start
—
End
—
Estimated
£1.2m
CPV
9. Anti-A1
Start
—
End
—
Estimated
£1.2m
CPV
10. Anti-Cw
Start
—
End
—
Estimated
£1.2m
CPV
11. Anti-K
Start
—
End
—
Estimated
£1.2m
CPV
12. Anti-k
Start
—
End
—
Estimated
£1.2m
CPV
13. Anti-Kpa
Start
—
End
—
Estimated
£1.2m
CPV
14. Anti-Kpb
Start
—
End
—
Estimated
£1.2m
CPV
15. Anti-P1
Start
—
End
—
Estimated
£1.2m
CPV
16. Anti-Lua
Start
—
End
—
Estimated
£1.2m
CPV
17. Anti-Lub
Start
—
End
—
Estimated
£1.2m
CPV
18. Anti-Coa
Start
—
End
—
Estimated
£1.2m
CPV
19. Anti-Cob
Start
—
End
—
Estimated
£1.2m
CPV
20. Anti-H
Start
—
End
—
Estimated
£1.2m
CPV
21. Anti-Wra
Start
—
End
—
Estimated
£1.2m
CPV
22. Anti-Vw
Start
—
End
—
Estimated
£1.2m
CPV
23. Coombs Control
Start
—
End
—
Estimated
£1.2m
CPV
24. Monoclonal Control
Start
—
End
—
Estimated
£1.2m
CPV
25. AB Serum
Start
—
End
—
Estimated
£1.2m
CPV
26. PeG
Start
—
End
—
Estimated
£1.2m
CPV
27. Anti-IgG
Start
—
End
—
Estimated
£1.2m
CPV
28. Anti-C3d
Start
—
End
—
Estimated
£1.2m
CPV
29. Poly AHG
Start
—
End
—
Estimated
£1.2m
CPV